SOHM Signs Exclusive Distribution Agreement for Generic Pharmaceutical Sales in the Philippines

BUENA PARK, CA--(Marketwire - June 16, 2009) - SOHM, Inc. (PINKSHEETS: SHMN), a generic pharmaceutical manufacturer that produces and markets generic drugs covering all major treatment categories announced today that the Company has signed an exclusive distribution agreement for generic pharmaceutical sales in the Philippines. The company expects steady sales increases in the 3rd quarter of 2009 due to purchase orders for generic pharmaceuticals and new generic drug launches. The Philippines pharmaceutical market is valued at US$1.8 billion per year and is growing at over 10% annually making it a viable international target market.

“SOHM is working to achieve our best 3rd quarter in the Company’s history with a strong performance in the Philippines and strong results in our other international markets like India,” stated Shailesh Shah, Vice President for Corporate Strategy at SOHM, Inc. “Based on our first-half results, as well as our outlook for the remainder of the year, we’re raising our 2009 forecast for both sales growth and earnings-per-share.”

About SOHM, Inc.

SOHM, Inc. is a generic pharmaceutical manufacturer that produces and markets generic drugs covering all major treatment categories. Global headquarters is located in North America with manufacturing sites in India. Generic pharmaceuticals are exported globally with a focus on distribution in emerging markets in Africa, Latin America, and Southeast Asia. www.sohm.com

Safe Harbor Statement

This press release contains statements, which may constitute “forward-looking statements” within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Those statements include statements regarding the intent, belief or current expectations of SOHM, Inc., and members of their management as well as the assumptions on which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements. Important factors currently known to management that could cause actual results to differ materially from those in forward-statements include fluctuation of operating results, the ability to compete successfully and the ability to complete before-mentioned transactions. The company undertakes no obligation to update or revise forward-looking statements to reflect changed assumptions, the statements to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating results.